Reference : Can we use bone turnover markers as targets for antiresorptive treatment in postmenop...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/189769
Can we use bone turnover markers as targets for antiresorptive treatment in postmenopausal osteoporosis ? an analysis from two phase 3 clinical trials.
English
BROWN, J.P. []
DAKIN, P. []
HADJI, P. []
McCLUNG, M.R. []
MILLER, P.D. []
Reginster, Jean-Yves mailto [Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
WAGMAN, R.B. []
WANG, A. []
McCLOSKEY, E. []
2015
Arthritis and Rheumatology
Wiley
67
S10
515-517
Yes (verified by ORBi)
No
International
2326-5191
2326-5205
2015 ACR/ARHP Annual Meeting
du 6 au 11 novembre 2015
American College of Rheumatology
San Francisco
Etats-Unis
http://hdl.handle.net/2268/189769

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
can we use bone turnover markers as targets for antiresorptive treatment in postmenopausal osteoporosis. An analysis from two phase 3 clinical trials.pdfAuthor postprint92.35 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.